Aviva launches €680 million shares buy-back

Insurance giant Aviva has announced a €682 million shares buy-back as part of efforts to deploy €2.3 billion of excess capital.

Alongside the buy-back, the group said €1 billion will be spent on debt reduction and €570 million on bolt-on acquisitions, confirming figures released in March.

Boss Mark Wilson said: "Aviva has significant surplus cash and capital and we are deploying €2.3 billion productively in 2018.

"The €682 million buy-back, together with our plan to repay €1 billion of expensive debt maturing this year and invest in bolt-on acquisitions, will grow Aviva's earnings, strengthen cashflow and improve debt ratios."

The move comes a day after Aviva pledged to make a €16 million "goodwill payment" to shareholders who lost out when it cancelled €511 million worth of preference shares, before the insurance giant U-turned on the plans.

The group said yesterday that it recognises the "uncertainty" created for preference shareholders and the impact the move had on its reputation, saying the payout is the "right thing" to do.

The goodwill payment will apply to those who sold preference shares between March 8 and March 22.

The FTSE 100 insurer believes fewer than 2,000 individual investors were affected.

The original proposal had drawn criticism from investors and the FCA, although Aviva said it had received legal advice that it could cancel its preference shares at par value.


Related Articles

More than 50% think whiplash payouts are too high

EU Irish car insurance probe eyes closure

Making cents: Insurance top-up may follow mortgage changes

Motorist's shock at €15,000 rise in insurance cover ... to over €19,000

More in this Section

US stocks take further losses as Turkey worries continue

Mincon untroubled by tariffs and Brexit

Ulster Bank €1.4bn home loans sale sparks row

Pre-tax loss at housebuilder Noonan rises to €6.9m

Today's Stories

Doubts Donald Trump’s growth spurt can be sustained


New father’s life ‘changed forever’ after he was run over by surgeon

More From The Irish Examiner